Literature DB >> 7519606

Localization, synthesis, and processing of surfactant protein SP-C in rat lung analyzed by epitope-specific antipeptide antibodies.

M F Beers1, C Y Kim, C Dodia, A B Fisher.   

Abstract

Surfactant protein C (SP-C), a 3.7-kDa hydrophobic lung-specific protein, is synthesized and secreted by pulmonary type II cells through proteolytic processing of a 21-kDa propeptide (SP-C21) by currently undefined pathways. Previously, we reported the production of a polyclonal antibody against rat SP-C21 (anti-CPROSP-C) using a synthetic peptide as the immunizing antigen (Beers, M. F., Wali, A., Eckenhoff, M. E. F., Feinstein, S., Fisher, J. H., and Fisher, A. B. (1992) Am. J. Respir. Cell. Mol. Biol. 7, 368-378). In this study, two additional epitope-specific proSP-C antibodies produced using synthetic peptide sequences were utilized to examine synthetic processing of SP-C. Anti-NPROSP-C (Met10-Gln23) and anti-CTERMSP-C (Ser149-Ser166) recognized native proSP-C21 produced from in vitro translation of SP-C cDNA. Immunocytochemistry using anti-NPROSP-C confirmed the localization of proSP-C peptides exclusively in type II cells. Western analysis of subcellular fractions identified a single 21-kDa band in microsomes and a 16-kDa form in lamellar bodies each recognized by all three antisera, while anti-NPROSP-C also uniquely identified a prominent 5-6-kDa form in lamellar bodies. In a perfused rat lung model labeled with [35S]cysteine/methionine, immunoprecipitation of lung homogenate and lamellar body fractions identified early appearances of 35S-labeled 21-, 18-, and 16-kDa SP-C forms in homogenate and a 16-kDa intermediate form in lamellar bodies. Anti-NPROSP-C also exclusively detected time-dependent appearances of 5-10-kDa proSP-C forms in lamellar bodies and homogenates. Processing of proSP-C21 was completely blocked by inclusion of brefeldin A (15 micrograms/ml) in the perfusate. These results demonstrate that synthetic peptides can be used to produce epitope-specific antisera which recognize more hydrophilic domains of proSP-C and show that proSP-C processing occurs intracellularly in subcellular compartments of type II cells which are distal to the trans-Golgi network.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519606

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C.

Authors:  Hanna Willander; Glareh Askarieh; Michael Landreh; Per Westermark; Kerstin Nordling; Henrik Keränen; Erik Hermansson; Aaron Hamvas; Lawrence M Nogee; Tomas Bergman; Alejandra Saenz; Cristina Casals; Johan Åqvistg; Hans Jörnvall; Helena Berglund; Jenny Presto; Stefan D Knight; Jan Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

2.  Pulmonary surfactant-associated polypeptide C in a mixed organic solvent transforms from a monomeric alpha-helical state into insoluble beta-sheet aggregates.

Authors:  T Szyperski; G Vandenbussche; T Curstedt; J M Ruysschaert; K Wüthrich; J Johansson
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

Review 3.  When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine.

Authors:  Michael F Beers; Yuben Moodley
Journal:  Am J Respir Cell Mol Biol       Date:  2017-07       Impact factor: 6.914

4.  Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotype.

Authors:  Naoya Fujino; Hiroshi Kubo; Rose A Maciewicz
Journal:  Lab Invest       Date:  2017-05-29       Impact factor: 5.662

5.  Distribution of surfactant proteins in type II pneumocytes of newborn, 14-day old, and adult rats: an immunoelectron microscopic and stereological study.

Authors:  Andreas Schmiedl; Matthias Ochs; Christian Mühlfeld; Georg Johnen; Frank Brasch
Journal:  Histochem Cell Biol       Date:  2005-09-27       Impact factor: 4.304

6.  A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy.

Authors:  Arie Hawkins; Susan H Guttentag; Robin Deterding; William K Funkhouser; Jennifer L Goralski; Shampa Chatterjee; Surafel Mulugeta; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-24       Impact factor: 5.464

7.  Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells.

Authors:  Anjali Jacob; Michael Morley; Finn Hawkins; Katherine B McCauley; J C Jean; Hillary Heins; Cheng-Lun Na; Timothy E Weaver; Marall Vedaie; Killian Hurley; Anne Hinds; Scott J Russo; Seunghyi Kook; William Zacharias; Matthias Ochs; Katrina Traber; Lee J Quinton; Ana Crane; Brian R Davis; Frances V White; Jennifer Wambach; Jeffrey A Whitsett; F Sessions Cole; Edward E Morrisey; Susan H Guttentag; Michael F Beers; Darrell N Kotton
Journal:  Cell Stem Cell       Date:  2017-09-28       Impact factor: 24.633

8.  A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.

Authors:  Markus Woischnik; Christiane Sparr; Sunčana Kern; Tobias Thurm; Andreas Hector; Dominik Hartl; Gerhard Liebisch; Surafel Mulugeta; Michael F Beers; Gerd Schmitz; Matthias Griese
Journal:  BMC Cell Biol       Date:  2010-11-20       Impact factor: 4.241

9.  Flow cytometric isolation of primary murine type II alveolar epithelial cells for functional and molecular studies.

Authors:  Marcus Gereke; Andrea Autengruber; Lothar Gröbe; Andreas Jeron; Dunja Bruder; Sabine Stegemann-Koniszewski
Journal:  J Vis Exp       Date:  2012-12-26       Impact factor: 1.355

10.  Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake.

Authors:  Sarah J Kemp; Andrew J Thorley; Julia Gorelik; Michael J Seckl; Michael J O'Hare; Alexandre Arcaro; Yuri Korchev; Peter Goldstraw; Teresa D Tetley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-06       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.